Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/32712

TitleAntimicrobial peptide combinations against Pseudomonas aeruginosa and Staphylococcus aureus
Author(s)Jorge, Paula Alexandra Silva
Alves, D.
Lourenço, Anália
Pereira, Maria Olívia
KeywordsAntimicrobial peptide combinations
Synergism
Pseudomonas aeruginosa
Staphylococcus aureus
Issue date2014
CitationJorge, P.; Alves, D.; Lourenço, Anália; Pereira, M. O., Antimicrobial peptide combinations against Pseudomonas aeruginosa and Staphylococcus aureus. AMP2014 – 4th International Symposium on Antimicrobial Peptides. Lorient, France, 4th-6th June, 195, 2014.
Abstract(s)Today, we are facing a major challenge regarding the development of new strategies and the discovery of new compounds with effective antimicrobial outcomes. The emergence of resistance is a preoccupant health threat and conventional antibiotics are being rendered ineffective. Researchers are now focusing in alternatives, such as the discovery of new antimicrobials with different modes of action, and the combination of agents potentiating their efficacy. AMPs are an example of new antimicrobials with promising applications, since they have different and sometimes unspecific mechanisms of action compared to traditional antibiotics, reducing the chance of acquired resistance. This work analyses AMP combinations against major pathogenic bacteria, Pseudomonas aeruginosa and Staphylococcus aureus, currently great contributors for resistance development and responsible for chronic infections, such as cystic fibrosis pneumonia. We present a screening of combinations of colistin with temporin A, citropin 1.1, tachyplesin I, lactoferricin B, magainin II and G10KHc, against these pathogens, including references and clinical isolate strains. Results show that most combinations have synergetic activities, which means that AMP combinations should be a viable way for the development of new antimicrobial treatments, thus reducing their toxicity and side effects, while maintaining efficacy. Some of the best combinations will be tested on biofilms of these bacteria, in order to test their prophylactic and therapeutic action against this different and more resilient mode of growth.
TypeAbstract
URIhttp://hdl.handle.net/1822/32712
Publisher versionhttp://amp2014.sciencesconf.org/
Peer-Reviewedyes
AccessOpen access
Appears in Collections:CEB - Resumos em Livros de Atas / Abstracts in Proceedings

Files in This Item:
File Description SizeFormat 
document_17812_1.pdf1,49 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID